Silicon Labs SVP granted 8,669 RSUs in Form 4

Silicon Laboratories Inc. executive Brandon Tolany reported an equity award of 8,669 shares of common stock.

Rhea-AI Filing Summary

Silicon Laboratories Inc. executive Brandon Tolany reported an equity award of 8,669 shares of common stock. The Form 4 shows a grant coded as an acquisition at a price of $0 per share, increasing his directly held stake to 71,050 common shares.

The award is in the form of restricted stock units (RSUs), with each RSU convertible into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the February 15, 2026 grant date under the company’s 2009 Stock Incentive Plan.

Insider Trade Summary

Grant/Award: 8,669 shares

Grant/Award 1 txn

Insider Tolany Brandon

Role Sr VP WW Sales & Marketing

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	8,669	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.0001 par value — 71,050 shares (Direct)

Footnotes (1)

1. F1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Silicon Laboratories (SLAB) report for Brandon Tolany?

Silicon Laboratories reported that Brandon Tolany received an equity award of 8,669 shares of common stock via a restricted stock unit grant. This increased his directly held beneficial ownership to 71,050 shares, as disclosed in the Form 4 filed for the February 15, 2026 transaction.

Was the Silicon Laboratories (SLAB) insider transaction a purchase or a grant?

The transaction was a grant, not an open-market purchase. The Form 4 uses transaction code A, described as a grant, award, or other acquisition, at a price of $0 per share, indicating compensation-related stock awarded to the reporting person rather than shares bought in the market.

How many Silicon Laboratories (SLAB) shares does Brandon Tolany own after this Form 4?

After the reported transaction, Brandon Tolany beneficially owns 71,050 shares of Silicon Laboratories common stock directly. This total reflects the 8,669-share restricted stock unit grant reported on the Form 4, added to his prior directly held share balance disclosed in the filing.

What are the vesting terms of the Silicon Laboratories (SLAB) RSU grant to Brandon Tolany?

The RSU grant vests in three equal annual installments. One-third of the 8,669 restricted stock units will vest on each of the first three anniversaries of the February 15, 2026 grant date, subject to the terms of Silicon Laboratories’ 2009 Stock Incentive Plan.

What position does Brandon Tolany hold at Silicon Laboratories (SLAB)?

Brandon Tolany serves as Senior Vice President, Worldwide Sales & Marketing at Silicon Laboratories. The Form 4 identifies him as an officer rather than a director or 10% owner, and reports this equity award as part of his compensation in that executive role.

How do the RSUs in this Silicon Laboratories (SLAB) filing convert into shares?

Each restricted stock unit in this award entitles the reporting person to receive one share of Silicon Laboratories common stock upon vesting. The RSUs will be settled in accordance with the company’s 2009 Stock Incentive Plan, as amended from time to time, after each scheduled vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 01:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tolany Brandon

(Last) (First) (Middle)

400 WEST CESAR CHAVEZ STREET

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILICON LABORATORIES INC. [ SLAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr VP WW Sales & Marketing

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	02/15/2026		A		8,669(1)	A	$0	71,050	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

Remarks:

	Saie-Yau Hui for Brandon Tolany	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.